FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Wednesday

 

Information Overload Precedes Lemtrada Infusions






























You know the saying about having too much of a good thing? I think that’s me, right now, as I think about starting infusions of the MS drug Lemtrada on December 5.

Lemtrada is supposed to be a super drug. As I wrote in an earlier column, my neurologist calls it “stem cell lite.” Some wheelchair-bound MS patients have been able to take some steps after completing a course of Lemtrada. Others report similar improvements in other symptoms.

There’s even a Facebook page where Lemtrada patients post selfies showing themselves smiling while hooked to their IVs and where they report about their experiences. This is where my information overload begins. This, I think, is why I’m nervous about starting this drug.

You see, the people who post on the Lemtrada page really tell it like it is. And, for every post about someone whose MS symptoms are improving, there’s another written by someone who’s having side-effects of chills, rashes or burning legs. At least it seems that way.

I’ve had a urinary infection basically since treatment in April….My lymph nodes have been so swollen and sore the last couple of days, I’ve had a fever and feel terrible. Praying for relief.”

I woke up this morning with three sores in my mouth. I have also been super fatigued, been having a lot of weird nerve pain, body pain and my mood has been really off for the last week or so. I have contacted my neurologist.”

Just completed my first cycle of Lemtrada now dealing with  symptoms without the running noise…”

I hate to admit it but I am getting very excited about the thought that the suffering of this long week could result in a cure… I will be disappointed if it does not”

On the other hand, there are patients who, it seems, don’t suffer any side effects.

It’s always been my feeling that the potential benefit of the MS drugs that I’ve used for 30+ years has outweighed the risk. So, I really can’t understand why the possibility of feeling “super tired,” feeling like I have the flu, or getting a sore in my mouth is bothering me.

I’ve always tried to get as much information as I can about things before I make a commitment, whether the commitment is to buying a car or booking a trip or using a drug. But I think I’ve reached the point where the information is hindering more than it’s helping my decision-making.  It’s information overload.

Story Source: The above story is based on materials provided by MULTIPLESCLEROSISNEWSTODAY
Note: Materials may be edited for content and length

Labels:



Go to Newer News Go to Older News